Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin 75mg vs 150mg for Preeclampsia Prevention
NCT07041385Not yet recruiting
- Sponsor
- Shalamar Hospital
- Start
- Nov 2025
- Primary completion
- Jun 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised trial of aspirin in preeclampsia (2 arms), sponsored by Shalamar Hospital. Primary endpoint: Pre-eclampsia at 9 months. Planned start Nov 2025; status: not yet recruiting.
02
Drugs
aspirin
03
Conditions
preeclampsia
Beyond the preview
Go deeper on NCT07041385.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07041385.